Lupin gets warning letter from USFDA for Somerset facility; shares dip over 3%
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility, Lupin said.
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility, Lupin said.
0 Comments
Post a Comment